Free express shipping on orders over $200
ELITE BIOTECH

Research overview

What is Retatrutide?

Retatrutide peptide (LY3437943) is an investigational synthetic peptide studied as a triple incretin receptor agonist acting on GIP, GLP-1, and glucagon receptors.

Triple incretin agonistInvestigational—not approved

Research use only · Not for human consumption · 18+.

How is Retatrutide classified in scientific research?

Retatrutide is a synthetic lipidated peptide studied across GIP, GLP-1, and glucagon receptor pathways in laboratory research.

Mechanism Studied in Research

Published studies have investigated Retatrutide in relation to:

  • GLP-1 Receptor Glucose-dependent insulin signaling.

  • GIP Receptor Glucose and lipid metabolism.

  • Glucagon Receptor Energy metabolism research.

These observations are based on published laboratory and scientific research only and should not be interpreted as evidence of clinical safety, effectiveness, or approved therapeutic use.

Research background

The Retatrutide peptide remains an investigational compound studied in published metabolic and endocrine research.

Purity, Testing and Handling

Researchers should verify Retatrutide using the matching COA and batch documentation before laboratory use.

References

  1. 1

    Coskun T, Urva S, Roell WC, et al. Cell Metabolism. 2022. PMID: 35985340

  2. 2

    Jastreboff AM, Kaplan LM, Frías JP, et al. New England Journal of Medicine. 2023. PMID: 37366315

  3. 3

    Li W, Zhou Q, Cong Z, et al. Cell Discovery. 2024. PMID: 39019866

Primary literature and reviews linked through PubMed. Citations are provided for scientific reference and do not imply a human-use indication.

Related